Question

Difficulty: Very hardRheumatology and Immunology

An athletic 24-year-old male construction worker presents with an 8-month history of insidious-onset lower back pain and severe morning stiffness. He reports that the stiffness often lasts for over an hour after awakening but gradually improves as he engages in physical labor throughout the day. His symptoms frequently awaken him in the second half of the night. He denies any radiating leg pain, numbness, or bowel/bladder dysfunction. Physical examination reveals a restricted range of motion in the lumbar spine, as evidenced by a modified Schober test expansion of only 3 cm3\text{ cm} (normal >5 cm>5\text{ cm}). Neurologic examination of the lower extremities is unremarkable.

Assuming the patient's initial imaging studies do not yield a definitive diagnosis and his symptoms remain unacceptably high despite initial interventions, arrange the following diagnostic and therapeutic steps in the most appropriate chronological sequence for establishing the diagnosis and managing this patient according to standard rheumatologic guidelines.

  1. 1Perform plain radiography of the sacroiliac joints
  2. 2Obtain magnetic resonance imaging (MRI) of the sacroiliac joints
  3. 3Prescribe a continuous, scheduled course of a nonsteroidal anti-inflammatory drug (NSAID)
  4. 4Assess clinical response and disease activity after a minimum of 2 to 4 weeks of pharmacotherapy
  5. 5Initiate treatment with a tumor necrosis factor-alpha (TNF-α) inhibitor

Answer

The correct sequence is: Plain radiography -> MRI of sacroiliac joints -> Continuous NSAID therapy -> Assessment after 2-4 weeks -> TNF-alpha inhibitor therapy.
The patient presents with classic features of inflammatory back pain (insidious onset, morning stiffness lasting >1 hour>1\text{ hour}, improvement with exercise, nighttime awakening), highly suspicious for axial spondyloarthritis (axSpA). The standard chronological approach begins with plain radiography of the sacroiliac joints to look for definitive structural damage. Because early disease often lacks radiographic changes, an MRI of the sacroiliac joints is the required next step if X-rays are negative or equivocal, as it can detect active osteitis. Once the diagnosis is established, the first-line pharmacologic intervention is a continuous, scheduled trial of NSAIDs. If the patient has persistently high disease activity upon reassessment after at least 22 to 44 weeks of continuous NSAID therapy, escalation to a biologic agent, such as a TNF-alpha inhibitor, is indicated.

Step-by-Step Solution

1
Select plain radiography of the sacroiliac joints as the initial step.
Initial assessment for structural damage is performed.
Guidelines require plain X-rays first due to wide availability and the ability to immediately establish a diagnosis of radiographic axial spondyloarthritis if classic changes are present.
2
Select MRI of the sacroiliac joints as the second step.
Detection of active osteitis/bone marrow edema.
In early disease, X-rays are often negative. MRI is required to diagnose non-radiographic axial spondyloarthritis when X-rays are non-diagnostic but clinical suspicion remains high.
3
Select the initiation of a continuous, scheduled NSAID course as the third step.
First-line pharmacotherapy is established.
Once diagnosis is confirmed, NSAIDs given at full anti-inflammatory doses on a continuous schedule (rather than PRN) are the primary treatment for axial spondyloarthritis.
4
Select the reassessment of disease activity after 2 to 4 weeks as the fourth step.
Verification of treatment failure or success.
A documented failure of a continuous NSAID trial is a strict prerequisite before escalating to more aggressive, expensive immunosuppressive therapies.
5
Select the initiation of a TNF-alpha inhibitor as the final step.
Escalation to second-line biologic therapy.
Biologic agents (like TNF or IL-17 inhibitors) are strictly reserved for patients with active disease who have failed to respond adequately to continuous NSAIDs.

Key Concept

The diagnostic and therapeutic escalation pathway for axial spondyloarthritis requires a stepwise approach: initial plain films followed by MRI if negative, then continuous NSAIDs as first-line therapy, culminating in biologic agents only if NSAIDs fail after a defined trial period.
Rate this question